Strategy Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?
zacks.com
Want to monitor FDMT?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor FDMT4DMT is a clinical-stage company harnessing the power of directed evolution for targeted gene therapies. 4DMT seeks to unlock the full potential of gene therapy using its platform, Therapeutic Vector Evolution, which combines the power of directed evolution with approximately one billion synthetic capsid sequences to invent evolved vectors for use in targeted gene therapy products. The company is initially focused in three therapeutic areas: ophthalmology, cardiology, and pulmonology.